• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较钴铬合金支架与不锈钢支架在急性心肌梗死直接经皮冠状动脉介入治疗中的应用:一项前瞻性注册研究。

Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry.

作者信息

Koh Angela S, Choi L M, Sim L L, Tan Jack W, Khin L W, Chua Terrance S J, Koh T H, Chia Stanley

机构信息

Department of Cardiology, National Heart Centre Singapore, Singapore.

出版信息

Acute Card Care. 2011 Dec;13(4):219-22. doi: 10.3109/17482941.2011.634011.

DOI:10.3109/17482941.2011.634011
PMID:22142201
Abstract

OBJECTIVES

To determine clinical outcome and rates of target vessel revascularization (TVR) in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI who were treated with cobalt-chromium stents compared to stainless steel bare metal stents (BMS).

BACKGROUND

The newer generation cobalt chromium stents were reported to achieve lower rates of TVR compared with conventional BMS.

METHODS

Consecutive STEMI cases admitted within 12 h of symptom onset and undergoing primary angioplasty and bare metal stent implantation 1 January 2002 and 31 December 2008 were identified. Primary outcomes were rates of clinically-driven TVR at six months as well as occurrence of major adverse cardiovascular events (MACE) either of all-cause death, repeat myocardial infarction or TVR at six months.

RESULTS

1030 cases with 1175 lesions (84% males) and median age of 58 years underwent primary PCI for STEMI in our registry. Overall procedural success rate was 98%. Stainless steel stents were inserted in 65% of the culprit lesions (stainless steel, n = 766 versus cobalt chromium, n = 264). Primary outcomes of TVR (3.5% in the stainless steel group and 3.4% in the cobalt chromium group, P = 0.93) and MACE (8.4% in the stainless steel group and 5.3% in the cobalt chromium group, P = 0.11) after six months were no different between the two groups. However, there were more deaths at 30 days in the stainless steel group compared to the cobalt chromium group (3.5% versus 0.4%, HR 4.04 (1.03-3.88), P = 0.04).

CONCLUSION

Both cobalt-chromium and stainless steel coronary stents were associated with similar and low risk of clinically-driven TVR.

摘要

目的

确定接受钴铬合金支架治疗的ST段抬高型心肌梗死(STEMI)患者在接受直接经皮冠状动脉介入治疗(PCI)后的临床结局和靶血管血运重建(TVR)率,并与不锈钢裸金属支架(BMS)进行比较。

背景

据报道,新一代钴铬合金支架的TVR率低于传统BMS。

方法

确定2002年1月1日至2008年12月31日期间症状发作12小时内入院并接受直接血管成形术和裸金属支架植入的连续STEMI病例。主要结局为6个月时临床驱动的TVR率以及6个月时主要不良心血管事件(MACE)的发生率,MACE包括全因死亡、再次心肌梗死或TVR。

结果

在我们的登记系统中,1030例患者共1175处病变(84%为男性)接受了STEMI的直接PCI,中位年龄为58岁。总体手术成功率为98%。65%的罪犯病变植入了不锈钢支架(不锈钢支架,n = 766;钴铬合金支架,n = 264)。两组6个月后的主要结局TVR(不锈钢组为3.5%,钴铬合金组为3.4%,P = 0.93)和MACE(不锈钢组为8.4%,钴铬合金组为5.3%,P = 0.11)无差异。然而,不锈钢组30天时的死亡人数多于钴铬合金组(3.5%对0.4%,HR 4.04(1.03 - 3.88),P = 0.04)。

结论

钴铬合金冠状动脉支架和不锈钢冠状动脉支架在临床驱动的TVR方面具有相似的低风险。

相似文献

1
Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry.比较钴铬合金支架与不锈钢支架在急性心肌梗死直接经皮冠状动脉介入治疗中的应用:一项前瞻性注册研究。
Acute Card Care. 2011 Dec;13(4):219-22. doi: 10.3109/17482941.2011.634011.
2
Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry.新型薄壁钴铬冠状动脉支架系统的临床安全性和疗效:真实世界 Coroflex Blue 注册研究结果。
Catheter Cardiovasc Interv. 2010 Jan 1;75(1):78-85. doi: 10.1002/ccd.22208.
3
Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.对接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的患者,内皮祖细胞捕获支架与西罗莫司洗脱生物可吸收聚合物涂层支架及裸金属支架的两年临床注册随访。
J Interv Cardiol. 2010 Apr;23(2):101-8. doi: 10.1111/j.1540-8183.2010.00534.x. Epub 2010 Mar 2.
4
Comparison of drug-eluting stents with bare metal stents implantation for the treatment of acute ST-elevation myocardial infarction: 2-year clinical outcomes from single-center registry.药物洗脱支架与金属裸支架置入治疗急性 ST 段抬高型心肌梗死的比较:单中心注册研究的 2 年临床结果。
Chin Med J (Engl). 2011 Mar;124(6):825-30.
5
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.雷帕霉素洗脱支架和紫杉醇洗脱支架与裸金属支架治疗ST段抬高型心肌梗死患者的六年临床结局比较:RESEARCH(鹿特丹心脏病医院评估的雷帕霉素洗脱支架)和T-SEARCH(鹿特丹心脏病医院评估的紫杉醇洗脱支架)注册研究分析
J Invasive Cardiol. 2011 Aug;23(8):336-41.
6
The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with acute ST-elevation myocardial infarction (The PROMETHEUS Study).促动力金属合金支架在急性ST段抬高型心肌梗死住院患者中的疗效和安全性(普罗米修斯研究)
J Invasive Cardiol. 2012 Jun;24(6):270-3.
7
Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).西罗莫司洗脱支架和紫杉醇洗脱支架与裸金属支架治疗ST段抬高型心肌梗死患者的三年临床结局比较(来自RESEARCH和T-SEARCH注册研究)
Am J Cardiol. 2007 Apr 15;99(8):1027-32. doi: 10.1016/j.amjcard.2006.11.070. Epub 2007 Mar 6.
8
Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.透析患者使用药物洗脱支架与裸金属支架进行经皮冠状动脉介入治疗后的临床结局
J Invasive Cardiol. 2006 Dec;18(12):577-83.
9
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.分期与“一次性”多血管经皮介入治疗急性心肌梗死的预后影响:来自 HORIZONS-AMI(急性心肌梗死中血管重建和支架与结局的协调)试验的分析。
J Am Coll Cardiol. 2011 Aug 9;58(7):704-11. doi: 10.1016/j.jacc.2011.02.071.
10
Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者行药物洗脱支架和金属裸支架经皮冠状动脉介入治疗的临床转归。
Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578.

引用本文的文献

1
Analysis of 12 Months Clinical Outcomes Associated with Implantation of Ultrathin (60 μm) Bare Metal Stent in an Unselected Real-world Population with Coronary Artery Disease.在未经选择的真实世界冠心病患者群体中,对植入超薄(60微米)裸金属支架的12个月临床结局进行分析。
J Clin Diagn Res. 2017 May;11(5):OC12-OC16. doi: 10.7860/JCDR/2017/24767.9896. Epub 2017 May 1.
2
Biomaterial applications in cardiovascular tissue repair and regeneration.生物材料在心血管组织修复与再生中的应用。
Expert Rev Cardiovasc Ther. 2012 Aug;10(8):1039-49. doi: 10.1586/erc.12.99.